Approval · Notice of Compliance 18703 · 2016
CYSVIEW: Notice of Compliance 18703
Issued November 22, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18703
- Date
- November 22, 2016
- Company
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updat the chemistry and manufacturing information and to chage the primary packagins
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSVIEW | Not yet assigned | — |
Medicinal ingredients
- HEXAMINOLEVULINATE HYDROCHLORIDE 100 MG per VIAL